Meta Platforms Inc. is seeking nuclear power developers to provide up to 4 gigawatts of nuclear energy for its data centers by the early 2030s, aligning with its AI and environmental goals.
Meta Platforms Inc. (NASDAQ:META), the parent company of Facebook, is making a significant move towards nuclear energy to power its data centers and support the U.S. electric grid. The company announced on Tuesday that it is seeking proposals from nuclear power developers to deliver between 1 to 4 gigawatts of nuclear generation capacity, with operations expected to commence in the early 2030s. This initiative is part of Meta's broader strategy to meet its artificial intelligence and environmental goals amid a projected surge in electricity demand.
The company emphasized the role of nuclear energy in providing a cleaner, more reliable, and diversified electric grid. According to estimates by Goldman Sachs, U.S. data center power use is anticipated to triple between 2023 and 2030, necessitating approximately 47 gigawatts of new generation capacity. However, the path to meeting this demand with nuclear power is fraught with challenges, including regulatory hurdles, potential uranium supply issues, and local opposition.
Meta's interest in nuclear energy follows similar moves by other tech giants. Microsoft and Constellation Energy recently announced a deal to restart a unit at the Three Mile Island plant in Pennsylvania, marking the first-ever restart for a data center. Similarly, Amazon.com Inc. has invested in a nuclear-powered data center from Talen Energy.
Meta is open to proposals for both small modular reactors, which are still emerging in the market, and larger reactors akin to the current U.S. nuclear fleet. The company is particularly interested in developers with expertise in community engagement, development, and permitting. The request-for-proposal process will remain open until January 3, 2025, allowing Meta to thoroughly evaluate potential projects given the capital-intensive and regulatory nature of nuclear energy compared to renewable sources like solar and wind.
This strategic move by Meta underscores the growing interest among tech companies in nuclear power as a viable solution to meet the increasing energy demands of data centers, driven by advancements in artificial intelligence and other technologies.
Chinese electric vehicle giant BYD is embroiled in controversy after Brazilian authorities discovered over 160 Chinese workers in 'slavery-like conditions' at a construction site for a new factory. The company has severed ties with the contractor involved and is cooperating with authorities.
South Korea's Shinsegae Group is partnering with Alibaba International to form a joint venture, aiming to challenge local e-commerce giants like Coupang and Naver.
Toyota Motor Corporation reported a decline in global production for the tenth consecutive month in November, despite achieving record sales driven by strong demand in the U.S. and China.
Toyota Motor North America has announced a $1 million donation to President-elect Donald Trump's inauguration, joining other major companies like Ford and GM. This move comes as Trump plans to impose tariffs that could impact automakers.
Iran has lifted its ban on WhatsApp and Google Play, marking a significant move towards easing internet restrictions. This decision is seen as a first step in scaling back some of the world's strictest internet controls.
Starbucks stock sees an uptick as striking baristas plan to return to work after a five-day strike, with negotiations set to resume.
Major banks and business groups have filed a lawsuit against the Federal Reserve, challenging the transparency and legality of the annual stress tests.
American Airlines experienced a nationwide ground stop due to a technical issue, affecting flights and causing stock fluctuations. Despite the disruption, the airline resumed operations with minimal long-term impact on its stock.
AstraZeneca and Daiichi Sankyo have withdrawn their EU marketing application for the lung cancer drug datopotamab deruxtecan following feedback from the European Medicines Agency.